These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
281 related items for PubMed ID: 8207529
21. Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. Tamarina NA, McMillan WD, Shively VP, Pearce WH. Surgery; 1997 Aug; 122(2):264-71; discussion 271-2. PubMed ID: 9288131 [Abstract] [Full Text] [Related]
22. Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2. Kayano K, Shimada T, Shinomiya T, Nakai S, Hisa Y, Aoki T, Seiki M, Okada Y. J Pathol; 2004 Apr; 202(4):403-11. PubMed ID: 15095267 [Abstract] [Full Text] [Related]
23. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Mackay AR, Ballin M, Pelina MD, Farina AR, Nason AM, Hartzler JL, Thorgeirsson UP. Invasion Metastasis; 1992 Apr; 12(3-4):168-84. PubMed ID: 1284126 [Abstract] [Full Text] [Related]
25. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis. Kossakowska AE, Edwards DR, Lee SS, Urbanski LS, Stabbler AL, Zhang CL, Phillips BW, Zhang Y, Urbanski SJ. Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979 [Abstract] [Full Text] [Related]
26. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines. Afzal S, Lalani el-N, Foulkes WD, Boyce B, Tickle S, Cardillo MR, Baker T, Pignatelli M, Stamp GW. Lab Invest; 1996 Feb; 74(2):406-21. PubMed ID: 8780160 [Abstract] [Full Text] [Related]
27. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance. Ozen O, Krebs B, Hemmerlein B, Pekrun A, Kretzschmar H, Herms J. Clin Cancer Res; 2004 Jul 15; 10(14):4746-53. PubMed ID: 15269148 [Abstract] [Full Text] [Related]
28. Co-expression of tissue inhibitor and matrix metalloproteinase in myocardium. Tyagi SC, Kumar SG, Banks J, Fortson W. J Mol Cell Cardiol; 1995 Oct 15; 27(10):2177-89. PubMed ID: 8576934 [Abstract] [Full Text] [Related]
29. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas. Airola K, Karonen T, Vaalamo M, Lehti K, Lohi J, Kariniemi AL, Keski-Oja J, Saarialho-Kere UK. Br J Cancer; 1999 May 15; 80(5-6):733-43. PubMed ID: 10360651 [Abstract] [Full Text] [Related]
30. Expression of proteinases and proteinase inhibitors during embryo-uterine contact in the pig. Menino AR, Hogan A, Schultz GA, Novak S, Dixon W, Foxcroft GH. Dev Genet; 1997 May 15; 21(1):68-74. PubMed ID: 9291582 [Abstract] [Full Text] [Related]
31. Increased gelatinolytic activity in keratoconus keratocyte cultures. A correlation to an altered matrix metalloproteinase-2/tissue inhibitor of metalloproteinase ratio. Kenney MC, Chwa M, Opbroek AJ, Brown DJ. Cornea; 1994 Mar 15; 13(2):114-24. PubMed ID: 8156782 [Abstract] [Full Text] [Related]
32. Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion. Ueda Y, Imai K, Tsuchiya H, Fujimoto N, Nakanishi I, Katsuda S, Seiki M, Okada Y. Am J Pathol; 1996 Feb 15; 148(2):611-22. PubMed ID: 8579123 [Abstract] [Full Text] [Related]
33. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary. Sakata K, Shigemasa K, Nagai N, Ohama K. Int J Oncol; 2000 Oct 15; 17(4):673-81. PubMed ID: 10995877 [Abstract] [Full Text] [Related]
34. Immunolocalization of matrix metalloproteinases and TIMP-1 (tissue inhibitor of metalloproteinases) in human gingival tissues from periodontitis patients. Meikle MC, Hembry RM, Holley J, Horton C, McFarlane CG, Reynolds JJ. J Periodontal Res; 1994 Mar 15; 29(2):118-26. PubMed ID: 8158500 [Abstract] [Full Text] [Related]
35. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes. Ries C, Loher F, Zang C, Ismair MG, Petrides PE. Clin Cancer Res; 1999 May 15; 5(5):1115-24. PubMed ID: 10353746 [Abstract] [Full Text] [Related]
36. Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells. Cha HJ, Bae SK, Lee HY, Lee OH, Sato H, Seiki M, Park BC, Kim KW. Cancer Res; 1996 May 15; 56(10):2281-4. PubMed ID: 8625299 [Abstract] [Full Text] [Related]
37. Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells. Janowska-Wieczorek A, Marquez LA, Matsuzaki A, Hashmi HR, Larratt LM, Boshkov LM, Turner AR, Zhang MC, Edwards DR, Kossakowska AE. Br J Haematol; 1999 May 15; 105(2):402-11. PubMed ID: 10233411 [Abstract] [Full Text] [Related]
38. Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas. Thorns V, Walter GF, Thorns C. Anticancer Res; 2003 May 15; 23(5A):3937-44. PubMed ID: 14666700 [Abstract] [Full Text] [Related]
39. Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors. Murashige M, Miyahara M, Shiraishi N, Saito T, Kohno K, Kobayashi M. Jpn J Clin Oncol; 1996 Oct 15; 26(5):303-9. PubMed ID: 8895669 [Abstract] [Full Text] [Related]
40. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells. Stetler-Stevenson M, Mansoor A, Lim M, Fukushima P, Kehrl J, Marti G, Ptaszynski K, Wang J, Stetler-Stevenson WG. Blood; 1997 Mar 01; 89(5):1708-15. PubMed ID: 9057654 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]